While concomitant radiochemotherapy (Stupp/CeTeG) was superior to monotherapy in IDH-wt glioblastoma (p=.0094) it is non-superior to sequential therapy (radiotherapy followed by chemotherapy) in IDH-wt astrocytoma (p=.1134). Here, IDH2 is linked to glioblastoma.